Recent advances in genetic systems in obligate intracellular human-pathogenic bacteria
The ability to genetically manipulate a pathogen is fundamental to discovering factors governing host-pathogen interactions at the molecular level and is critical for devising treatment and prevention strategies. While the genetic "toolbox" for many important bacterial pathogens is extensi...
Saved in:
Published in | Frontiers in cellular and infection microbiology Vol. 13; p. 1202245 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
19.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The ability to genetically manipulate a pathogen is fundamental to discovering factors governing host-pathogen interactions at the molecular level and is critical for devising treatment and prevention strategies. While the genetic "toolbox" for many important bacterial pathogens is extensive, approaches for modifying obligate intracellular bacterial pathogens were classically limited due in part to the uniqueness of their obligatory lifestyles. Many researchers have confronted these challenges over the past two and a half decades leading to the development of multiple approaches to construct plasmid-bearing recombinant strains and chromosomal gene inactivation and deletion mutants, along with gene-silencing methods enabling the study of essential genes. This review will highlight seminal genetic achievements and recent developments (past 5 years) for
spp.,
spp.,
spp., and
including progress being made for the still intractable
. Alongside commentary of the strengths and weaknesses of the various approaches, future research directions will be discussed to include methods for
.
that should have utility in the other obligate intracellular bacteria. Collectively, the future appears bright for unraveling the molecular pathogenic mechanisms of these significant pathogens. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-2 Edited by: Rey Carabeo, University of Nebraska Medical Center, United States Reviewed by: Hector Alex Saka, Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI) (CONICET), Argentina; Ulrike G. Munderloh, University of Minnesota Twin Cities, United States |
ISSN: | 2235-2988 2235-2988 |
DOI: | 10.3389/fcimb.2023.1202245 |